Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2023
Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registryFeng Xie, Ruilin Quan, Gangcheng Zhang, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 17, 2024
A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertensionFang Wang, Ling Liu, Hongyun Ruan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 14, 2024
Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trialYundai Chen, Lei Gao, Qin Qin, et al.
Oxidative Medicine and Cellular Longevity|July 4, 2020
Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 SignalingTangzhiming Li, Suqi Li, Yilu Feng, et al.
JACC. Cardiovascular Interventions|December 8, 2018
Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized TrialYida Tang, Shubin Qiao, Xi Su, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical TrialR James White, Carlos Jerjes-Sanchez, Gisela Martina Bohns Meyer, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 17, 2020
Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trialJian Tian, Yi-da Tang, Shubin Qiao, et al.
Respirology (Carlton, Vic.)|September 21, 2020
Characteristics and long-term survival of patients with chronic thromboembolic pulmonary hypertension in ChinaLimin Deng, Ruilin Quan, Yuanhua Yang, et al.
Advances in Therapy|December 6, 2023
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label ExtensionEkkehard Grünig, Franck Rahaghi, Jean Elwing, et al.
BMC Pulmonary Medicine|April 21, 2021
Risk prediction in medically treated chronic thromboembolic pulmonary hypertensionRuilin Quan, Yuanhua Yang, Zhenwen Yang, et al.
Pageof 8